“Studies that examine the benefits of superhydrophillic catheters, which reduce blood clots and blood stream infections caused by mid-lines and PICC lines would be welcome, as this study compares one defective product to another,” states Greg Vigna, MD, JD, national sepsis attorney. Dr. Greg Vigna, MD, JD, national sepsis attorney and product liability attorney, states, “There [...]
“Polyurethane PICC lines are defective because they do little to reduce the risk of hospital acquired infections,” states Greg Vigna, MD, JD, national sepsis attorney. What is reported by Dr. Cesar Arias, MD, Ph.D, in his article “Changing Trends in the Sources and Volumes of Clinical Cultures with Candida auris at a Large Health System, 2019-2023” [...]
“Without a doubt this is a serious health concern for the public as infusion companies and manufacturers of polyurethane PICC lines continue to market and profit from cheap, obsolete technology that does nothing to reduce the risk of venous catheter associated bloodstream infections. There are safer designs that reduce these risks,” states Greg Vigna, MD, [...]
“Our review underscores a significant link between the use of vasopressors and the development of intensive care unit-acquired weakness in critically ill adult patients,” says Dr. Xiuming Xi, Department of Critical Care Medicine, Capital Medical University, Beijing, China. What does Dr. Xi report regarding Vasopressors and ICU-acquired weakness (ICUAW) in the article published in Brain [...]
“Of particular concern is the increasing incidence of healthcare associated endocarditis, which accounts for 7% to 29% of endocarditis cases seen at tertiary care hospitals. This trend parallels the increasing use of central venous catheters,” states Dr. Michael Chrissoheris, MD. What did Dr. Chrissoheris report in his article, “Endocarditis Complicating Central Venous Catheter Bloodstream Infections: [...]
“Collectively, the artificial vascular endothelium coating (AVEC) should provide a novel, safe and generalized anti-thromboinflammation strategy for diverse blood-contacting medical devices," states Shuangyang Li, Investigator, School of Chemical Engineering and Technology, Tianjin University, China. Dr. Greg Vigna, MD, JD, national malpractice attorney and PICC line sepsis attorney, says, “Central-line associated bloodstream infections are increasing because [...]
“The probability of antimicrobial initiation among patients with new hospital-onset sepsis declined at shift changes and overnight. Time to antimicrobial initiation for patients with sepsis onset overnight was four times longer than for patients with onset during the day," states Dr. Jennifer C. Ginestra, MD, Critical Care. Dr. Greg Vigna, MD, JD, national PICC line [...]
“If patients survive, those with mild polyneuropathy may recover within weeks and those with more severe forms within months. Unusually severe forms may be associated with incomplete recovery, resulting in persistent motor handicaps," states Ernst Hund, M.D., Neurologist. Greg Vigna, MD, JD, national decubitus ulcer attorney, explains, “I have managed dozens of patients with severe [...]
“More than 20% of hospitalizations for sepsis among U.S. adults occur in patients with cancer, and the incidence of sepsis is increased by a factor of approximately 40 among patients receiving long-term hemodialysis," states Nuala J Meyer, M.D. Dr. Greg Vigna, MD, JD, national PICC line attorney, states, “Polyurethane PICC lines, dialysis catheters, and ports [...]
“There doesn’t appear to be any long-term benefit of providing Remodulin IV when compared to Sub-Cutaneous injection. The risk of blood infections from intravenous administration of Remodulin using venous access devices such as PICC lines and Ports appear to be unreasonable given there is no long-term benefit other than local pain at the incision site," [...]
